Neoleukin Therapeutics In... (NLTX)
NASDAQ: NLTX
· Real-Time Price · USD
3.49
0.05 (1.45%)
At close: Dec 18, 2023, 10:00 PM
Neoleukin Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.81 | -0.34 | -0.73 | -0.66 | -2.42 | -5.59 | -0.68 | -0.52 | -0.71 | -0.91 | -1.69 | -4.38 | -6.45 | -8.39 | -11.31 |
PEG Ratio | 0.01 | -0.00 | 0.07 | n/a | -0.02 | 0.07 | -0.05 | -0.59 | 0.04 | n/a | -2.33 | 3.06 | -2.94 | -11.41 | -0.99 |
PS Ratio | n/a | 9.69 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 44.27K | 66.38K | n/a | n/a |
PB Ratio | 0.25 | 0.21 | 0.43 | 0.32 | 0.58 | 0.59 | 0.48 | 0.30 | 0.33 | 0.49 | 0.80 | 1.86 | 2.57 | 3.04 | 3.78 |
P/FCF Ratio | -3.4 | -1.34 | -1.3 | n/a | -10.27 | -11.15 | -2.88 | -2.55 | -3.68 | -4.93 | -7.13 | -21.14 | -42.63 | -35.11 | -46.82 |
P/OCF Ratio | -3.53 | -1.34 | -1.32 | n/a | -10.27 | -11.51 | -2.98 | -2.58 | -3.81 | -5.03 | -7.36 | -21.83 | -45.49 | -38.26 | -50.63 |
OCF/S Ratio | n/a | -7.2 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.03K | -1.46K | n/a | n/a |
Debt / Equity Ratio | 0.04 | 0.04 | 0.10 | 0.09 | 0.14 | 0.14 | 0.14 | 0.13 | 0.11 | 0.11 | 0.10 | 0.09 | 0.09 | 0.08 | 0.08 |
Quick Ratio | 21.03 | 20.84 | 9.09 | 12.17 | 15.33 | 17.17 | 11.97 | 8.96 | 10.63 | 12.78 | 17.16 | 16.67 | 17.40 | 22.09 | 21.57 |
Current Ratio | 21.03 | 20.84 | 9.09 | 12.17 | 15.33 | 17.17 | 11.97 | 8.96 | 10.63 | 12.78 | 17.16 | 16.67 | 17.40 | 22.09 | 21.57 |
Asset Turnover | n/a | 0.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | n/a | n/a |
Interest Coverage | 12.96K | 4.9K | 7.39K | 5.03K | n/a | n/a | n/a | -17.5 | -24.35 | -81.81 | -1.18K | -3.03K | -2.57K | -3.03K | -4.98K |
Return on Equity | -0.08 | -0.16 | -0.15 | -0.12 | -0.06 | -0.03 | -0.17 | -0.14 | -0.12 | -0.13 | -0.12 | -0.11 | -0.1 | -0.09 | -0.08 |
Return on Assets | -0.07 | -0.14 | -0.12 | -0.1 | -0.05 | -0.02 | -0.14 | -0.12 | -0.1 | -0.11 | -0.1 | -0.09 | -0.09 | -0.08 | -0.07 |
Return on Invested Capital | -0.09 | -0.16 | -0.15 | -0.12 | -0.06 | -0.03 | -0.23 | -0.13 | -0.11 | -0.12 | -0.11 | -0.1 | -0.09 | -0.08 | -0.08 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.05 | n/a | n/a | n/a |
Gross Profit Margin | n/a | 0.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.00 | 1.00 | n/a | n/a |
Net Profit Margin | n/a | -7.08 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.53K | -2.57K | n/a | n/a |
Pretax Profit Margin | n/a | -7.95 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.53K | -2.57K | n/a | n/a |
Operating Profit Margin | n/a | -8.61 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.53K | -2.57K | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -9.15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.42K | -2.48K | n/a | n/a |